Givaudan | GIVN - Cost Of Sales


Givaudan reported CHF2.07B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Air Liquide EUR 6.28B 378.3M Jun/2026
Akzo Nobel EUR 1.5B 95M Jun/2026
Anheuser-Busch USD 7.08B 462M Jun/2026
Arkema EUR 1.94B 144.9M Jun/2026
BASF EUR 12.87B 1.01B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Beiersdorf EUR 2.06B 50M Dec/2025
British American Tobacco GBP 3.36B 243M Jun/2026
Covestro EUR 2.7B 5.39B Dec/2025
Croda International GBP 445.5M 221.15M Dec/2024
Danone EUR 8.68B 1.95B Jun/2026
Diageo GBP 4.08B 166M Dec/2025
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
Heineken EUR 13.29B 579M Jun/2026
Henkel EUR 4.99B 37M Jun/2026
International Flavors Fragrances USD 1.18B 686M Jun/2026
Johnson Matthey GBP 6.9B 1.86B Jun/2026
Lonza CHF 2.28B 189M Jun/2025
L'Oréal EUR 6B 377.9M Jun/2026
Merck EUR 2.27B 199M Jun/2026
Nestle CHF 23.12B 1.97B Jun/2026
Pernod Ricard EUR 2.14B 99M Dec/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
SGS CHF 445M 522M Jun/2025
Sika AG CHF 2.77B 49.8M Dec/2025
Solvay EUR 928M 52M Jun/2026
Umicore EUR 13.24B 3.49B Jun/2026
Victrex GBP 86.8M 6.8M Jun/2026